Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (241-250 of 750) with videos related to

Pageof 75
Sort By:
Hepatology (Baltimore, Md.)|April 17, 2012
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosisRohit Loomba, Maria Abraham, Aynur Unalp, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2024
Letter: Filling the Gaps-Enhancing MASLD Prognosis With Imaging, Diverse Populations and Extended Follow-Up. Authors' ReplyNobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
Alimentary Pharmacology & Therapeutics|April 26, 2024
Long-term clinical outcomes in steatotic liver disease and incidence of liver-related events, cardiovascular events and all-cause mortalityNobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
Nutrients|June 10, 2023
Association of Diet Quality with Metabolic (Dysfunction) Associated Fatty Liver Disease in Veterans in Primary CareNatalia I Heredia, Aaron P Thrift, David J Ramsey, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 8, 2022
Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver DiseaseDaniel Q Huang, Suzanne R Sharpton, Maral Amangurbanova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 29, 2014
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studiesSiddharth Singh, Alina M Allen, Zhen Wang, et al.
Alimentary Pharmacology & Therapeutics|May 7, 2020
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare dataRohit Loomba, Robert Wong, Jeremy Fraysse, et al.
Nature Reviews. Gastroenterology & Hepatology|May 23, 2018
Publisher Correction: The gut-liver axis and the intersection with the microbiomeAnupriya Tripathi, Justine Debelius, David A Brenner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2008
Placebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trialsRohit Loomba, Robert Wesley, Frank Pucino, et al.
Plos One|April 20, 2012
Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo studyJeffrey K Lee, Ricki Bettencourt, David Brenner, et al.
Pageof 75

Showing results (241-250 of 750) with videos related to

Sort By:
Pageof 75
Hepatology (Baltimore, Md.)|April 17, 2012
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosisRohit Loomba, Maria Abraham, Aynur Unalp, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2024
Letter: Filling the Gaps-Enhancing MASLD Prognosis With Imaging, Diverse Populations and Extended Follow-Up. Authors' ReplyNobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
Alimentary Pharmacology & Therapeutics|April 26, 2024
Long-term clinical outcomes in steatotic liver disease and incidence of liver-related events, cardiovascular events and all-cause mortalityNobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
Nutrients|June 10, 2023
Association of Diet Quality with Metabolic (Dysfunction) Associated Fatty Liver Disease in Veterans in Primary CareNatalia I Heredia, Aaron P Thrift, David J Ramsey, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 8, 2022
Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver DiseaseDaniel Q Huang, Suzanne R Sharpton, Maral Amangurbanova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 29, 2014
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studiesSiddharth Singh, Alina M Allen, Zhen Wang, et al.
Alimentary Pharmacology & Therapeutics|May 7, 2020
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare dataRohit Loomba, Robert Wong, Jeremy Fraysse, et al.
Nature Reviews. Gastroenterology & Hepatology|May 23, 2018
Publisher Correction: The gut-liver axis and the intersection with the microbiomeAnupriya Tripathi, Justine Debelius, David A Brenner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2008
Placebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trialsRohit Loomba, Robert Wesley, Frank Pucino, et al.
Plos One|April 20, 2012
Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo studyJeffrey K Lee, Ricki Bettencourt, David Brenner, et al.
Pageof 75